Cerebrospinal fluid detection of interleukin-1β in phase of remission predicts disease progression in multiple sclerosis

Brain atrophy and lesion load predict long term disability in multiple sclerosis

(2013) Veronica Popescu et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

The switch between relapse and remission in multiple sclerosis: Continuous inflammatory response balanced by Th1 suppression and neurotrophic factors

(2012) Michael Gurevich et al.   JOURNAL OF NEUROIMMUNOLOGY

Interleukin-1β causes synaptic hyperexcitability in multiple sclerosis

(2011) Silvia Rossi et al.   ANNALS OF NEUROLOGY

Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis

(2011) S Rossi et al.   Multiple Sclerosis Journal

Prediction of long-term disability in multiple sclerosis

(2011) R Schlaeger et al.   Multiple Sclerosis Journal

Early central atrophy rate predicts 5 year clinical outcome in multiple sclerosis

(2010) C. Lukas et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis

(2010) Axel Petzold et al.   LANCET NEUROLOGY

Gray matter atrophy and disability progression in patients with early relapsing–remitting multiple sclerosis

(2009) Dana Horakova et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Gray matter atrophy is related to long-term disability in multiple sclerosis

(2008) Leonora K. Fisniku et al.   ANNALS OF NEUROLOGY

Disability and T2 MRI lesions: a 20-year follow-up of patients with relapse onset of multiple sclerosis

(2008) L. K. Fisniku et al.   BRAIN

Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS

(2008) Richard A. Rudick et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Increase of CD4+TNFα+IL-2−T cells in cerebrospinal fluid of multiple sclerosis patients

(2008) N Shi et al.   Multiple Sclerosis Journal